Company profile: SensoDetect
1.1 - Company Overview
Company description
- Provider of medical device technology to help detect mental illness.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to SensoDetect
Neurelis
HQ: United States
Website
- Description: Provider of specialty pharmaceutical therapies addressing unmet medical needs, including VALTOCO, a prescription nasal spray for short-term treatment of seizure clusters in patients aged 6 and older; and pipeline programs NRL-1004 for acute agitation using proprietary Intravail delivery technology, and NRL-1049 for cerebral cavernous malformations, potentially the first FDA-approved treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neurelis company profile →
Titan Pharmaceuticals
HQ: United States
Website
- Description: Provider of proprietary therapeutics and subdermal implant drug delivery solutions targeting serious medical disorders. Offerings include ProNeura, a continuous, long-term subdermal delivery platform for chronic conditions; Probuphine, a buprenorphine implant for maintenance treatment of opioid use disorder in clinically stable patients taking 8 mg or less of oral buprenorphine daily; and a nalmefene implant to prevent relapse after detoxification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Titan Pharmaceuticals company profile →
Cerus Endovascular
HQ: United Kingdom
Website
- Description: Provider of interventional neuroradiology devices and delivery systems, including the e-clipse aneurysm occlusive device that addresses neurovascular aneurysm procedures currently attempted by surgical clipping, minimally invasive metal coils, and liquid embolics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cerus Endovascular company profile →
Helicon Therapeutics
HQ: United States
Website
- Description: Provider of therapeutics to treat disorders of cognition, developed through understanding the genetic basis of long-term memory formation; originating from the neuroscience program at Cold Spring Harbor Laboratory.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Helicon Therapeutics company profile →
Aspen Neuroscience
HQ: United States
Website
- Description: Provider of personalized, autologous iPSC-derived neuron replacement therapies for Parkinson’s disease. Pipeline includes ANPD001, a personalized cell therapy for sporadic Parkinson’s disease in IND-enabling studies, and ANPD002, a gene-corrected autologous neuron therapy targeting genetic variants, focusing on the GBA gene.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aspen Neuroscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for SensoDetect
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to SensoDetect
2.2 - Growth funds investing in similar companies to SensoDetect
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for SensoDetect
4.2 - Public trading comparable groups for SensoDetect
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →